0001562180-24-005021.txt : 20240612
0001562180-24-005021.hdr.sgml : 20240612
20240612193257
ACCESSION NUMBER: 0001562180-24-005021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240610
FILED AS OF DATE: 20240612
DATE AS OF CHANGE: 20240612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Jonathan C
CENTRAL INDEX KEY: 0001655016
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 241039712
MAIL ADDRESS:
STREET 1: C/O MYOKARDIA, INC.
STREET 2: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-262-7002
MAIL ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-06-10
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001655016
Fox Jonathan C
C/O EDGEWISE THERAPEUTICS, INC.
1715 38TH STREET
BOULDER
CO
80301
true
false
false
false
false
Stock Option (Right to Buy)
17.13
2024-06-10
4
A
false
20594.00
0.00
A
2025-06-10
2034-06-10
Common Stock
20594.00
20594.00
D
100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders.
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
2024-06-12